Results 31 to 40 of about 576,900 (305)

Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections.

open access: yesClinical Infectious Diseases, 2020
BACKGROUND This guidance document provides recommendations to clinicians for the treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa ...
P. Tamma   +5 more
semanticscholar   +1 more source

Plasmid Transfer by Conjugation in Gram-Negative Bacteria: From the Cellular to the Community Level

open access: yesGenes, 2020
Bacterial conjugation, also referred to as bacterial sex, is a major horizontal gene transfer mechanism through which DNA is transferred from a donor to a recipient bacterium by direct contact.
Chloé Virolle   +4 more
semanticscholar   +1 more source

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria

open access: yesClinical Infectious Diseases, 2019
Carbapenem resistance in gram-negative bacteria has caused a global epidemic that continues to grow. Although carbapenemase-producing Enterobacteriaceae have received the most attention because resistance was first reported in these pathogens in the ...
P. Nordmann, L. Poirel
semanticscholar   +1 more source

A new antibiotic selectively kills Gram-negative pathogens

open access: yesNature, 2019
The current need for novel antibiotics is especially acute for drug-resistant Gram-negative pathogens1,2. These microorganisms have a highly restrictive permeability barrier, which limits the penetration of most compounds3,4.
Y. Imai   +29 more
semanticscholar   +1 more source

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

open access: yesClinical Infectious Diseases, 2019
Antimicrobial resistance has become one of the greatest threats to public health, with rising resistance to carbapenems being a particular concern due to the lack of effective and safe alternative treatment options.
Y. Doi
semanticscholar   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

open access: yesFEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

Function‐driven design of a surrogate interleukin‐2 receptor ligand

open access: yesFEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang   +9 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Permeability barriers of Gram‐negative pathogens

open access: yesAnnals of the New York Academy of Sciences, 2020
Most clinical antibiotics do not have efficacy against Gram‐negative pathogens, mainly because these cells are protected by the permeability barrier comprising the two membranes with active efflux.
H. Zgurskaya, V. Rybenkov
semanticscholar   +1 more source

Extended-spectrum ß-lactamases in gram negative bacteria

open access: yesJournal of Global Infectious Diseases, 2010
Extended-spectrum ß-lactamases (ESBLs) are a group of plasmid-mediated, diverse, complex and rapidly evolving enzymes that are posing a major therapeutic challenge today in the treatment of hospitalized and community-based patients.
Deepti Rawat, Deepthi Nair
doaj   +1 more source

Home - About - Disclaimer - Privacy